stock
IRD · Opus Genetics, Inc.
What Opus Genetics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live IRD price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on IRD.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 83,195,823 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -513.5%
- Net
- -1091.8%
Returns
- ROE
- —
- ROA
- -115.7%
Health
- Current ratio
- 12.2x
- Debt/equity
- —
Deep value
- NCAV
- -$13.26M
- NCAV per share
- -$0.16
- Price/NCAV
- Locked
- NNWC
- -$16.36M
- NNWC per share
- -$0.20
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $755,000 | —Gross profit: unreported by this company. | -$16.48M | -$8.10M | 10-Q filed 2026-08-06 |
| 2026-03-31 | $2.16M | —Gross profit: unreported by this company. | -$14.36M | -$65.53M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $3.87M | —Gross profit: unreported by this company. | -$11.45M | -$16.52M | 10-K filed 2026-03-12 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $3.08M | —Gross profit: unreported by this company. | -$8.31M | -$17.45M | 10-Q filed 2025-11-12 |
| 2025-06-30 | $2.88M | —Gross profit: unreported by this company. | -$8.91M | -$7.42M | 10-Q filed 2026-08-06 |
| 2025-03-31 | $4.37M | —Gross profit: unreported by this company. | -$9.93M | -$8.19M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $4.30M | —Gross profit: unreported by this company. | -$38.03M | -$35.13M | 10-K filed 2026-03-12 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $3.87M | —Gross profit: unreported by this company. | -$8.01M | -$7.53M | 10-Q filed 2025-11-12 |
- Assets
- $92.97M
- Equity
- -$12.99M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $14.20M | -$38.60M | -$49.59M | — |
| 2024-12-31 | $10.99M | -$62.07M | -$57.53M | — |
| 2023-12-31 | $19.05M | -$10.56M | -$9.99M | — |
| 2022-12-31 | $39.85M | $18.23M | $17.89M | — |
| 2021-12-31 | $589,000 | -$22.70M | -$56.69M | — |
| 2020-12-31 | $0 | -$19.97M | -$24.62M | -$6.80M |
| 2019-12-31 | $3.00M | -$4.19M | -$6.17M | -$3.62M |
| 2018-12-31 | — | -$20.54M | -$14.37M | — |
| 2017-12-31 | — | -$17.35M | -$25.29M | — |
| 2016-12-31 | — | -$16.41M | -$9.31M | — |
Company filings
since Thu Aug 6 · 1 offering filing in 12 months
events
5% owners ()
Perceptive Advisors LLC
Stake update
Caligan Partners LP
Stake update
BALYASNY ASSET MANAGEMENT L.P.
Stake update
Foundation Fighting Blindness Retinal Degeneration Fund
Stake update
Nantahala Capital Management, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Foundation Fighting Blindness Retinal Degeneration Fund
Director
Sale$2,755,981Oct 2, 7:47 PM ET
Gagnon Robert E.
Chief Financial Officer
Sale$127,212Sep 8, 4:05 PM ET
YERXA BENJAMIN R
President, Director
Sale$22,064Jul 27, 4:08 PM ET
SCHACHLE JOSEPH K
Chief Operating Officer
Sale$13,653Jul 27, 4:07 PM ET
Magrath George
Chief Executive Officer, Director
Sale$27,926Jul 27, 4:07 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named IRD, and the market events around them.
Sign in to see thisBoard
The IRD board could not be loaded.
Retry the IRD boardnakagai
Signals on IRD come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the IRD board